Nucleus H Xu, PhD

Research Assistant Professor
University of Pennsylvania, United States

Presentation(s):

• 8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results

  Friday, March 22, 2024
  10:52am – 11:02am ET